Relative Roles of TGF-β and IGFBP-5 in Idiopathic Pulmonary Fibrosis
2011
The Roles of TGF-β and IGFBP-5 in Pulmonary Fibrosis
publication
Evidence: moderate
Author Information
Author(s): Sureshbabu A., Tonner E., Allan G. J., Flint D. J.
Primary Institution: Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde
Hypothesis
What are the distinct roles of TGF-β and IGFBP-5 in the development of idiopathic pulmonary fibrosis?
Conclusion
IGFBP-5 may enhance epithelial cell repair and could be a promising target for antifibrotic therapies.
Supporting Evidence
- Idiopathic pulmonary fibrosis has no FDA approved treatments.
- TGF-β1 is a major profibrotic factor that induces cell death in epithelial cells.
- IGFBP-5 enhances epithelial cell survival and may limit scarring.
- Both TGF-β1 and IGFBP-5 activate mesenchymal cells to increase collagen production.
Takeaway
This study looks at two important proteins, TGF-β and IGFBP-5, and how they affect lung scarring. While TGF-β can harm lung cells, IGFBP-5 helps them heal.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website